Alaska: SB193

Bill Summary

AK SB193 establishes a new regulatory framework allowing naturopaths in Alaska to obtain temporary and permanent endorsements to prescribe and administer certain prescription drugs. The bill creates a pathway where naturopaths can earn a temporary endorsement by passing a pharmacology examination and working under physician supervision for one year, after which a supervising physician recommends whether they receive full endorsement, continued supervision, or denial. The legislation also sets continuing education requirements of 30 hours of general education plus additional pharmacotherapy training for endorsed naturopaths. The bill maintains safety guardrails by prohibiting naturopaths from prescribing controlled substances, cancer chemotherapeutic drugs, antipsychotic medications, and administering therapeutic radiation. Overall, the bill modernizes Alaska's naturopathic licensing structure to clarify professional standards while enabling qualified practitioners to expand their scope of practice.

Why It Matters to MAHA

This bill advances health freedom by recognizing naturopaths as qualified healthcare providers and expanding their ability to serve patients who seek naturopathic care as an alternative or complement to conventional medicine. By creating a clear endorsement pathway rather than continuing to restrict naturopathic prescribing, the legislation increases patient choice and access to a broader range of practitioners and treatment approaches. The competency-based framework, including pharmacology examination requirements and continuing education, demonstrates that expanded scope can coexist with meaningful patient safety standards. MAHA supports this approach because it removes unnecessary regulatory barriers that artificially limit competition and patient autonomy while maintaining accountability through transparent credentialing and supervision requirements. This bill exemplifies how health freedom and patient safety can work together rather than in opposition.